SOFIA, Bulgaria: Bulgarian triple jumper Gabriela Petrova, runner-up at the 2015 European indoor titles in Prague, has denied any wrongdoing in the wake of testing positive for the banned substance meldonium.
"I have not damaged, at all, the counter doping principles and I can proceed onward with my head held high," Petrova told a news meeting at the Vasil Levski stadium on Monday.
"I quit taking this medicine in September. I haven't touched it in 2016," she included.
Meldonium, which helps blood stream and builds the measure of oxygen taken in by the body, permitting competitors to recoup speedier while preparing, was added to the World Anti-Doping Agency's rundown of banned substances on January 1.
From that point forward, more than 100 competitors have been found to have utilized it.
Petrova, who additionally completed fourth at the world open air titles in Beijing a year ago, fizzled an out-of-rivalry medication test on February 6.
The 23-year-old has joined an extensive rundown of competitors, including previous world tennis number one Maria Sharapova of Russia, who have recorded positive tests for meldonium.
The Bulgarian had hauled out of the world indoor titles in Portland, Oregon prior this month.
"She was prepared to win the world title, however I chose it was better not to take part since we got the data about the positive test a few days before the title," said mentor Atanas Atanasov.
Petrova, named Bulgaria's Athlete of the Year in December, is trusting she will dodge a suspension and have the capacity to contend at the Rio Olympics in August.
"I trust reality will be uncovered," she said. "It doesn't sound intelligent for 150 competitors to have taken the banned substance in an Olympic year," she included.
The utilization of meldonium was far reaching before the boycott.
One study indicated 490 competitors finally year's European Games in Baku had taken it.
Grindeks, the Latvian organization that is the principle supplier of the medication, says the substance could shield competitors from cell harm, however is unrealistic to enhance their execution
No comments:
Post a Comment